Quanterix Corp

Insider buying at Quanterix shows CFO Sriram Vandana’s confidence in a potential FDA‑cleared Alzheimer’s test, hinting at upside amid a low‑price, negative‑P/E stock.

Quanterix insider buy signals long‑term confidence: director’s 23k zero‑cost R‑stock units suggest optimism amid exec sell‑offs, hinting at future upside.